Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
294,683,714
-
Total 13F shares
-
79,366,997
-
Share change
-
+1,174,430
-
Total reported value
-
$993,813,520
-
Put/Call ratio
-
70%
-
Price per share
-
$12.53
-
Number of holders
-
189
-
Value change
-
+$8,744,496
-
Number of buys
-
81
-
Number of sells
-
108
Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q1 2021
As of 31 Mar 2021,
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) was held by
189 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
79,366,997 shares.
The largest 10 holders included
WASATCH ADVISORS INC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, CREDIT SUISSE AG/, JPMORGAN CHASE & CO, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, and Nuveen Asset Management, LLC.
This page lists
189
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.